Donor Chimerism at Day +90 Predicts Better Survival Outcomes Among Allogeneic Hematopoietic Cell Transplantation Recipients Receiving Myeloablative Conditioning

Key Points

• Improved survival outcomes associate strongly with high levels of donor chimerism.
• The analysis indicated that donor chimerism was a predictor of survival at Day +90 post-transplant.
• Assessment of donor chimerism occurs at the 90-day mark after myeloablative conditioning.
• Findings suggest donor chimerism may serve as an important biomarker for transplantation success.